New efforts develop therapeutic antibodies.
Since the development of monoclonal antibodies twenty-five years ago, researchers and biotech companies have been looking to develop therapeutic uses for them. Michael Gross looks at some of the latest efforts.
Gross
M
M
D000818:Animals; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D001709:Biotechnology; D015195:Drug Design; D004345:Drug Industry; D006801:Humans
D000911:Antibodies, Monoclonal